Completed
Randomized Strategy Trial Cryptococcal Optimal ART Timing (COAT) Trial Uganda and South Africa
Class Central Classrooms beta
YouTube videos curated by Class Central.
Classroom Contents
Update on Cryptococcal Disease in HIV-Infected Patients - Lecture 7
Automatically move to the next video in the Classroom when playback concludes
- 1 Intro
- 2 Overview
- 3 Laboratory-confirmed cryptococcosis in SA GERMS
- 4 Burden of cryptococcal meningitis (Gauteng Province)
- 5 Case fatality rate: South Africa
- 6 CrAg Lateral Flow Assay
- 7 Implementation and challenges
- 8 ORCAS trial
- 9 Open label RCT in Vietnam (n = 299)
- 10 WHO Guidelines 2011
- 11 Case scenario
- 12 IRIS meta-analysis
- 13 Trials of ART timing in cryptococcal meningitis prior to the COAT trial
- 14 Randomized Strategy Trial Cryptococcal Optimal ART Timing (COAT) Trial Uganda and South Africa
- 15 COAT Trial Treatment for Cryptococcal Meningitis
- 16 Causes of death
- 17 Early ART initiation particularly harmful if
- 18 What was cause of excess mortality with early ART in COAT/Zimbabwe trial?
- 19 Day 14 CSF findings
- 20 Conclusions (1)
- 21 Conclusions (2)
- 22 Acknowledgements
